Immunopathological Analysis in a French National Cohort of Membranous Nephropathy
Recruiting
N/A
Interventional Study
Membranous Nephropathy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 400 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Nice · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
National cohort of all cases of membranous nephropathy (MN) during a 1 year period in France, based on a pathological and/or serological diagnostic, collecting the data on:
* incidence of MN
* prevalence of anti-PLA2R1 and anti-THSD7A
* clinical outcome one year after diagnosis or after relapse (complete remission, partial remission or persistent nephrotic syndrome)
* environmental risk factors f…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18 years or more
* Biopsy on a native kidney consistent with MN and/or positivity for serum anti-PLA2R1 and/or anti-THSD7A antibodies
* Signed informed consent
Exclusion Criteria:
* Diagnosis error based on the kidney biopsy staining or on serology analyses for the posit…
Contacts